{
    "clinical_study": {
        "@rank": "73722", 
        "arm_group": {
            "arm_group_label": "catheter ablation", 
            "arm_group_type": "Other"
        }, 
        "brief_summary": {
            "textblock": "The purpose of this study is to determine whether left atrium substrate based ablation plus\n      circumferential is effective in the treatment of persistent and long-standing atrial\n      fibrillation."
        }, 
        "brief_title": "Left Atrium Substrate Based Ablation Plus Circumferential Pulmonary Vein Isolation to Treat Chronic Atrial Fibrillation", 
        "completion_date": {
            "#text": "December 2012", 
            "@type": "Anticipated"
        }, 
        "condition": "Atrial Fibrillation", 
        "condition_browse": {
            "mesh_term": "Atrial Fibrillation"
        }, 
        "eligibility": {
            "criteria": {
                "textblock": "Inclusion Criteria:\n\n        All persistent or permanent AF patients with refractory or intolerant to at least one\n        Class 1 or Class 3 antiarrhythmic medication.\n\n        Exclusion Criteria:\n\n          1. Patients with paroxysmal AF (self-terminating episodes lasting < 7 day)\n\n          2. Patients who have had a previous AF ablation procedure\n\n          3. Pregnancy"
            }, 
            "gender": "Both", 
            "healthy_volunteers": "No", 
            "maximum_age": "80 Years", 
            "minimum_age": "18 Years"
        }, 
        "enrollment": {
            "#text": "87", 
            "@type": "Anticipated"
        }, 
        "firstreceived_date": "October 23, 2012", 
        "has_expanded_access": "No", 
        "id_info": {
            "nct_id": "NCT01716143", 
            "org_study_id": "2011-SR-014"
        }, 
        "intervention": {
            "arm_group_label": "catheter ablation", 
            "intervention_name": "radiofrequency catheter ablation", 
            "intervention_type": "Procedure"
        }, 
        "is_fda_regulated": "No", 
        "keyword": [
            "atrial fibrillation", 
            "catheter ablation", 
            "Mapping"
        ], 
        "lastchanged_date": "October 25, 2012", 
        "location": {
            "contact": {
                "email": "chenminglong@njmu.edu.cn", 
                "last_name": "Minglong Chen, MD", 
                "phone": "0086-25-68136965"
            }, 
            "facility": {
                "address": {
                    "city": "Nanjing", 
                    "country": "China", 
                    "state": "Jiangsu", 
                    "zip": "210029"
                }, 
                "name": "Division of Cardiology, the First Affiliated Hospital of Nanjing Medical University"
            }, 
            "investigator": {
                "last_name": "Minglong Chen, MD", 
                "role": "Principal Investigator"
            }, 
            "status": "Recruiting"
        }, 
        "location_countries": {
            "country": "China"
        }, 
        "number_of_arms": "1", 
        "official_title": "Left Atrium Substrate Based Ablation Plus Circumferential Pulmonary Vein Isolation in the Treatment of Persistent and Long-standing Atrial Fibrillation", 
        "overall_contact": {
            "email": "chenminglong@njmu.edu.cn", 
            "last_name": "Minglong Chen, MD", 
            "phone": "0086-25-6813-6965"
        }, 
        "overall_status": "Recruiting", 
        "oversight_info": {
            "authority": "China: Food and Drug Administration"
        }, 
        "phase": "N/A", 
        "primary_completion_date": {
            "#text": "June 2012", 
            "@type": "Actual"
        }, 
        "primary_outcome": {
            "measure": "The primary study end point was freedom from atrial arrhythmias off antiarrhythmic drugs at 3,6,12,18 and 24 months after a single-ablation. procedure.", 
            "safety_issue": "Yes", 
            "time_frame": "3 years"
        }, 
        "required_header": {
            "download_date": "ClinicalTrials.gov processed this data on June 04, 2014", 
            "link_text": "Link to the current ClinicalTrials.gov record.", 
            "url": "http://clinicaltrials.gov/show/NCT01716143"
        }, 
        "responsible_party": {
            "investigator_affiliation": "The First Hospital of Nanjing Medical University", 
            "investigator_full_name": "Youquan Wei", 
            "investigator_title": "Clinical Investigator", 
            "responsible_party_type": "Principal Investigator"
        }, 
        "secondary_outcome": {
            "measure": "The percentage of macro-reentrant atrial tachycardia in recurrent arrhythmias after atrial fibrillation ablation", 
            "safety_issue": "Yes", 
            "time_frame": "December 31, 2012"
        }, 
        "source": "The First Hospital of Nanjing Medical University", 
        "sponsors": {
            "lead_sponsor": {
                "agency": "The First Hospital of Nanjing Medical University", 
                "agency_class": "Other"
            }
        }, 
        "start_date": "March 2010", 
        "study_design": "Endpoint Classification: Efficacy Study, Intervention Model: Single Group Assignment, Masking: Open Label, Primary Purpose: Treatment", 
        "study_type": "Interventional", 
        "verification_date": "October 2012"
    }
}